期刊文献+

阿仑磷酸钠联合高压氧治疗老老年骨质疏松的疗效观察 被引量:3

原文传递
导出
摘要 目的 观察阿仑磷酸钠联合高压氧治疗对老老年骨质疏松的疗效.方法 将122例老老年骨质疏松疼痛患者(≥80岁)按随机数字分组法分为2组,每组61例,治疗组给予阿仑磷酸钠结合高压氧治疗,对照组仅给予阿仑磷酸钠治疗,在治疗6个月后对两组疼痛情况及对骨代谢标志物骨钙素(N-MID)、骨碱性磷酸酶(BAP)、Ⅰ型前胶原氨基末端前肽(PINP)和Ⅰ型骨胶原C端肽(CTX)水平进行检测.结果 治疗后两组患者腰背疼痛症状均有所改善,治疗组患者疼痛改善幅度显著优于对照组(P<0.01).治疗组与对照组比较血清N-MID、BAP、PINP、CTX水平均有明显降低(P<0.01).结论 阿仑磷酸钠联合高压氧治疗对老老年骨质疏松患者具有较好的治疗作用.
出处 《中国医师杂志》 CAS 2013年第8期1085-1087,共3页 Journal of Chinese Physician
  • 相关文献

参考文献10

二级参考文献34

  • 1葛雪琳,蔡桂英.骨转换生化标志物与骨质疏松[J].中国骨质疏松杂志,1999,5(2):85-88. 被引量:28
  • 2林守清.雌激素对骨质疏松的防治及在骨转换中作用[J].中华医学杂志,2005,85(11):728-729. 被引量:30
  • 3中国老年学学会骨质疏松委员会“手册”编写专家组.中国人群骨质疏松诊疗手册.中国骨质疏松杂志,2007,13:2-2.
  • 4Delaney MF.Strategies for the prevention and treatment of osteoporosis during early postmenopause[J].Am J Obs Gyn,2006,194(2Suppl):12-23.
  • 5Huopio J,Kroger H,Honkanen R,et al.Risk facter for perimenopausal fractures:a prospective study[J].Osteoporos Int,2000,11(3):219-227.
  • 6Trovas GP,Lyritis GP,Galanos A,et al.A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis:effects on bone mineral density and bone markers[J].J Bone Miner Res,2002,17(3):521-527.
  • 7Smith E,Coetzee GA,Frenkel B.Lueocortieoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3β[J].J Biol Chen,2002,277(20):18191-18197.
  • 8Roger MJ.From molds and macrophages to mevalonate:a decade of progress in understanding the molecular mode of action of bisphosphonates[J].Calcif Tissue Int,2004,75(6):451-461.
  • 9Garnero P,Mulleman D,Munoz F,et al.Long-term variability of markers of bone turnover in postmenopausal woman and implication for their clinical use:the OFELY study[J].J Bone Miner Res,2003,18(10):1789-1794.
  • 10Tromp AM,Oms ME,Popp-Snijders C,et al.Predictors of fractures in elderly women[J].Osteoporos Int,2000,11(2):134-140.

共引文献1980

同被引文献34

  • 1刘晖,杨启菁.高压氧在手术治疗小腿皮肤难愈创面中的应用[J].中华创伤骨科杂志,2006,8(7):693-694. 被引量:18
  • 2黄辉,陈开明,李可可.高压氧联合耐信治疗难治性消化性溃疡的疗效观察[J].现代医药卫生,2006,22(21):3274-3275. 被引量:2
  • 3Steinbrech DS, Longaker NT, Mehrara B J, et aL Fibrnhlast re- sponse to hypoxia:the relationship between angiogenesis and ma- trix regulation[ J]. J Surg Res, 1999,84 ( 2 ) : 127-133.
  • 4黎国屏,李清怀.高压氧对烧伤创面的影响[J].河北医科大学学报,1999,20(2):108-122.
  • 5Brown JP, Morin S, Leslie W, et al. Bisphosphonates for treat- ment of osteoporosis: expected benefits, potential harms, and drug holidays [J]. Can Faro Physician, 2014,60(4) :324-333.
  • 6Reyes C, Hitz M, Prieto-Alhambra D, et al. Risks and Benefits of Bisphosphonate Therapies [ J ]. J Cell Biochem, 2016 , 117 ( 1 ) : 20-28. DOI : 10. 1002/jcb. 25266.
  • 7Lewiecki EM. Bisphosphonates for the treatment of osteoporosis: insights for clinicians [ J ]. Ther Adv Chronic Dis, 2010,1 ( 3 ) :115-128. DOI: 10. 1177/2040622310374783.
  • 8Miller PD, Jarnal SA, Evenepoel P, et al. Renal safety in patients treated with bisphosphonates for osteoporosis : a review[ J]. J Bone Miner Res, 2013 ,28 (10) :2049-2059. DOI: 10. 1002/jbmr. 2058.
  • 9Hirsehberg R. Renal complications from bisphosphonate treatment [J]. Curt Opin Support Palliat Care, 2012,6 (3) : 342-347. DOI: 10. 1097/SPC. 0b013e328356062e.
  • 10Shih AW, Weir MA, Clemens KK, et al. Oral bisphosphonate use in the elderly is not assoeiated with acute kidney injury[ J]. Kid- ney Int, 2012,82(8) :903-908. DOI: 10. 1038/ki. 2012. 227.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部